Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BLOC-2 complex member HPS5 (abbreviated HPS5) is a subunit of the Biogenesis of Lysosome-related Organelles Complex-2 (BLOC-2) and plays a crucial role in the formation and function of lysosomes and highly specialized organelles, notably melanosomes and platelet dense granules. The complex is composed of HPS3, HPS5, and HPS6 proteins, and participates in vesicular trafficking and organelle biogenesis. Mutations in the HPS5 gene are causative for Hermansky-Pudlak syndrome type 5, an autosomal recessive disorder characterized by albinism and bleeding diathesis due to impaired organelle formation[1][5][3][8]. There is no established evidence that HPS5 is a druggable target, and there are no drugs known to directly interact with it.
Not applicable; no drugs target HPS5 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BLOC-2 complex member HPS5 (HPS5).